James A Perry

Title: James A Perry: Innovator in Medical Treatments

Introduction

James A Perry is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical treatments, particularly in addressing issues related to bone mineral density and lipid levels. With a total of 3 patents, Perry's work has the potential to impact many lives.

Latest Patents

Perry's latest patents include innovative methods for treating decreased bone mineral density using zinc and ring finger 3 (ZNRF3) inhibitors. This patent outlines methods for identifying patients at risk of developing decreased bone mineral density and detecting human ZNRF3 variant nucleic acid molecules and polypeptides. Another significant patent focuses on treating increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors. This patent provides methods for identifying subjects at risk of developing increased lipid levels and detecting human SREBF1 variant nucleic acid molecules and polypeptides.

Career Highlights

Throughout his career, James A Perry has worked with esteemed organizations such as the University System of Maryland and Regeneron Pharmaceuticals, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas in medical treatments.

Collaborations

Perry has collaborated with notable colleagues, including Da-Wei Gong and Alan R Shuldiner. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

James A Perry is a distinguished inventor whose work in medical treatments has the potential to make a significant difference in patient care. His innovative patents reflect his commitment to improving health outcomes through scientific research and collaboration.